Talk:Statin
From Wikipedia, the free encyclopedia
| This is the talk page for discussing improvements to the Statin article. This is not a forum for general discussion of the subject of the article. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
| Archives: 1, 2, 3Auto-archiving period: 2 months |
| Statin was nominated as a Natural sciences good article, but it did not meet the good article criteria at the time (May 19, 2024, reviewed version). There are suggestions on the review page for improving the article. If you can improve it, please do; it may then be renominated. |
| Mevalonate inhibition was nominated for deletion. The discussion was closed on 07 June 2009 with a consensus to merge. Its contents were merged into Statin. The original page is now a redirect to this page. For the contribution history and old versions of the redirected article, please see its history; for its talk page, see here. |
| This It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Statin.
|
| Text and/or other creative content from this version of Mevalonate inhibition was copied or moved into Statin with this edit. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists. |
Citation Issue
Under the "medical uses" section the quote: 'A 2022 systematic review found the absolute risk reductions for three hard outcomes – all-cause mortality, myocardial infarction, and stroke – to be 0.8%, 1.3%, and 0.4%, respectively (relative risk: 9%, 29%, 14%).' does not carry a citation. In addition I am familiar with this study and these results are only over the several year period the study was undertaken. It is misleading because it allows the user to come to the conclusion this is the benefit if the medications are taken indefinitely. Qpro18 (talk) 04:25, 4 February 2026 (UTC)
